Introduction
The diabetic foot can be divided into two characteristic types: the neuropathic foot, in which neuropathy predominates, and the neuroischaemic foot, in which occlusive vascular disease is the main factor although neuropathy may be present in a variable degree. It is essential to differentiate between these two entities because each requires distinct therapeutic approaches.
The neuropathic foot is characterized by palpable pulses and thus does not usually require revascularization. In contrast, the neuroischaemic foot has absent pulses and is complicated by rest pain, ulceration and gangrene. The main factor responsible for reduction in blood supply to the foot is macrovascular disease of the arteries of the leg. The concomitant presence of neuropathy in the ischaemic foot predisposes to minor trauma which leads to ulceration and this is often complicated by infection.
Medical management is indicated if the ulcer is small and shallow and is of recent onset within the previous month. This consists of debridement, control of infection and pain, relief of oedema, and footwear to accommodate deformity and protect the margins of the foot. With such medical treatment up to 72% of ischaemic ulcers can be healed.' If such medical treatment is not © Edward Arnold 1995 successful, or if the patient presents with extensive ulceration or tissue necrosis, then urgent revascularization should be considered.
The purpose of this article is to consider critically the role of angioplasty in revascularization of the ischaemic diabetic foot. However, it is important initially to review the nature and distribution of the macrovascular disease which renders the foot susceptible to ulceration and which requires reopening to accelerate healing of the ischaemic foot.
Macrovascular disease
Macrovascular disease in the diabetic leg can occur at the iliac, femoral, popliteal and tibial re~ons and this leads to a reduction in the perfusion of the foot. However, 40% of diabetic patients who have no pedal pulses and gangre-!10~s I~sions still have a palpable popliteal pulse, indicating patent iliac and femoral arteries.s
In comparison with nondiabetics , diabetics have been noted to have a lower incidence of aortoiliac disease, the same incidence of femoropopliteal disease and a higher incidence of involvement of the arteries distal to the popliteal artery.s The deep femoral artery is also more frequently diseased. The propensity for diabetics to have more diffuse vessel involvement tends to produce an unfavourable environment for the development of a satisfactory collateral circulation.
Nature of macrovascular disease
Two pathologies exist in the arteries of the diabetic leg and foot: atherosclerosis and medial wall calcification. The macroscopic features of streaks and plaques of atheroma are indistinguishable in diabetics and nondiabetics although the distribution is different. 3 They occur more frequently and at an earlier stage and appear to progress more rapidly in the diabetic patient. The actual pathology of the large vessel wall is not much different from that of the atherosclerotic nondiabetic artery. The intima is thickened by fatty deposits of cholesterol plaques which occur most commonly at bifurcations and the posterior wall of arteries and where the artery is constricted by muscle and fascia in the adductor canal. Whereas the occlusive process frequently involves a single segment of an artery in the nondiabetic, atherosclerosis tends to be multisegmental in the diabetic.
Calcification of the tunica media of the muscular arteries is a common feature of longstanding diabetes. In addition, medial calcification commonly affects the arteries of the foot which are seldom affected by atherosclerosis. Medial calcification is much more common in diabetics, and its frequency has been related to age, male sex and duration of diabetes." Neubauer made the interesting observation that calcification of the vessels of nondiabetics was related to higher levels of blood glucose following a glucose load." Recent studies have linked calcification with neuropathy.6,7 The effect of calcified vessels on the blood supply to the foot remains controversial. Arterial calcification is associated with a reduction in peak blood flow which is an index of the capacity of the circulation to increase.s However, other studies have shown no deficit in oxygen-carrying power of the blood in patients with medial arterial calcification.?
Distribution of macrovascular disease
The distribution of macrovascular disease has been investigated by both morphological and arteriographic studies.
Morphological studies
Strandness et al. 10 studied the pattern of arterial occlusion in amputated extremities from 17 diabetics and 19 nondiabetics. The arteries of the legs were more frequently occluded in the diabetic patients at 81% compared with 57% in the nondiabetic patients. Furthermore, the aortoiliac arteries were more frequently involved in the non diabetics -68% compared with 27% in the diabetics. Both differences were significant. Conradt! studied the occlusion pattern in ten legs from diabetics and ten legs from nondiabetic patients, amputated for severe vascular disease. Casts were made of the vascular lumina by injecting acrylic plastic into the arteries. A semiquantitative expression for the degree of vessel occlusion was obtained by adding the percentage of total vessel length occluded completely to half the percentage of partially occluded. In the calf arteries, the index tended to be higher in diabetics, 62%, compared with 52% in the nondiabetics. However, in the pedal arteries, the index was reduced in the diabetic group at 6% compared with 12% in the nondiabetics.
There have been few studies of the foot arteries in the diabetic foot, and it is difficult to assess their true significance as foot artery disease would have to be extremely severe to interfere appreciably with tissue perfusion because of the foot's excessive collateral network. Ferrierrs studied 20 limbs amputated because of chronic ischaemia in ten diabetic and ten nondiabetic patients. The incidence of obstruction in the two groups was identical in larger arteries, including the popliteal, tibial and peroneal, plantar, dorsalis pedis and plantar arch arteries. In the metatarsal arteries, luminal reduction was much more frequent in diabetics at 60% compared with 21% in nondiabetics. In addition, the digital arteries showed occlusions in 19% of diabetics compared with 10% in nondiabetics. There was a significant relationship between severe medial calcification of the arteries of the feet and the presence of arterial obstruction. Medial calcification was found at all levels and was more widespread in diabetic arteries.
Arteriographic studies
These have shown that diabetics often have diffuse involvement including superficial femoral, popliteal and tibial arteries, and an increased frequency of occlusive disease in the calf arteries compared with the iliac arteries.
Notably, Tingaud et al. described the typical area where the lesions were most marked as the 'leg tripod' at the end of the popliteal artery and at the tibial peroneal trunk at the beginning of the leg arteries.P Thrombosis was very frequently found here. These findings were confirmed by Olivier et a/., who in a comparison between 1760 arteriosclerotic occlusions and 304 arterial lesions in diabetics noted that the frequency of subpopliteal lesions to be definitely higher at 27.6% in diabetics compared with 14% in nondiabetics.t-Furthermore, the frequency of femoropopliteal lesions was similar in diabetics at 53% compared with nondiabetics at 62%. This confirms the diffuse involvement of occlusive disease previously reported in radiological stUdies when diffuse artherosclerosis occurred in 75.4% diabetics compared with 42% in nondiabetic patients. IS Van der Stricht et al. compared proximal iliac and femoral lesions in diabetics with those in nondiabetics and pure peripheral lesions in the same groups.!" The appearances of the proximal lesions were similar in both groups. However, in the peripheral lesions, the findings were totally different. There was a total absence of peripheral calcification in the nondiabetic group, whereas it was almost the rule in the diabetic group.
In summary, both the radiological and histological studies indicate that the arterial disease of the lower extremities is different in diabetics and nondiabetics. The main difference seems to be in the pattern of arterial occlusion, in that the distal arteries are apparently more severely affected in diabetes and are associated with calcification of the medial wall.
Angioplasty and the diabetic foot
Macrovascular disease can thus occur at iliac, femoral, popliteal and tibial levels. As to relative frequency, a recent study of 17 ischaemic diabetic limbs that were suitable for angioplasty demonstrated only one site in the iliac arteries, 13 in the superficial femoral, three in the popliteal and four in the tibial arteries.t?
The indications for angioplasty at these sites, as part of the treatment of the diabetic foot, will now be considered and previous experience in this field reviewed. There are often problems in interpreting the published results of angioplasty at different sites and from different series. Patient selection, different correlates of success together with variable long-term follow-up all contrive to make comparison between series difficult.
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Lesions that respond best to angioplasty are the same as in the nondiabetic population, in that they should ideally be short segment, single, concentric stenoses. In general, lesions longer than 5 em, occlusions and eccentric lesions will do worse. However it is not just the character of the lesion itself that is important. The state of the inflow and run-off vessels is critical to the success of angioplasty whether proximal or distal. It is also important to note that angioplasty can also be important in maintaining secondary patency of femoropopliteal and femorodistal grafts by dilating outflow stenoses.
Since the development of angioplasty, the effect of diabetes on the eventual outcome following dilatation has remained uncertain. Two groups have reported a significantly poorer outcome in diabetic patients,18,19 whereas others have shown no difference in angioplasty.w-u In general, diabetes has been regarded as a relative contraindication to angioplasty because of the multisegmental nature of arterial disease. Indeed, when factors that influence interventional management were examined, diabetics were 23% less likely to undergo angioplasty than were nondiabetics.P
The effect of diabetes on the outcome of angioplasty for lower limb ischaemia was reviewed by Davies et al. regarding their experience with 425 lesions dilated in 370 patients.P The cumulative patency at five years for iliac lesions in nondiabetics was 61.2% and in diabetics was 35.6% (p < 0.05), and for superficial femoral and popliteal artery lesions, patency was 4?%~n no.ndiab~tic subjects compared with 38% In diabetic patients (not significant). The need for subsequent surgical intervention and risk of death were both significantly greater in the diabetic group.
This review will concentrate on the usefulness of angioplasty for ulceration and gangrene in the diabetic foot. The relative roles of angioplasty In the three regions, iliac, femoropopliteal and below knee, will be considered.
Iliac disease
In nondiabetics, iliac disease does not cause critical ischaemia unless there is additional distal disease. In patients with critical ischaemia due to multi segmental disease, correction of the proximal lesion is essential if treatment of a distal lesion is to succeed. However, in the diabetic foot, neuropathy may predispose a foot with reduced tissue perfusion due to iliac disease alone, to trauma leading to ulceration. Treatment of this iliac disease is necessary to improve blood supply to the foot and accelerate healing of ulceration.
Iliac lesions are particularly suited to angioplasty, being technically easy to perform with success rates and long-term patency similar to those of nondiabetics. The ideal lesions for angioplasty are stenotic lesions and occlusions up to 5 em in length. If occlusions longer than 5 em are angioplastied, there is a risk of distal embolization. However, long occlusions may be treated when there is a total contraindication to surgery. The operative mortality rate for aortofemoral bypass grafting is 2.3%, rising to 4.7% in patients over 65 years, and 5.5% when the procedure is performed for limb salvage.e' The long-term patency rates for iliac angioplasty are equivalent to that for bypass surgery but angioplasty has a technical failure rate of 5-7%. The mortality rate for iliac angioplasty is essentially zero and the elderly diabetic patient may be more suitable for iliac angioplasty than for bypass surgery. Reported five-year patency rates for iliac angioplasty vary from 60% to 90% in nondiabetic patients. Rates of 70% are described in diabetics who have a good run-off but poor run-off reduces the five-year patency to approximately 20%,21 and, indeed, a recent review has shown that longterm iliac patency rates are reduced in diabetics at 38.8% compared with 61.2% in nondiabetics.P
Femoropopliteal disease
Several studies have assessed the role of angioplasty of femoropopliteal lesions in critical ischaemia.25-- 28 Blair et al., in a retrospective study, compared the results of angioplasty with those of infrainguinal bypass procedures in patients with critical ischaemia.27 In patients treated for limb-threatening ischaemia, the two-year patency after femoropopliteal bypass was 68% and for femoral distal bypass was 47%, which was significantly better than that of 18% from angioplasty. However limb salvage after angioplasty was 78%, which was not significantly different from that after femoropopliteal bypass (90%), or femorodistal bypass (74%), although the angioplasty group required a significantly greater number of subsequent procedures compared to the surgery group (59% vs 33%, p < 0.01). However, this study has been criticized bec~use of po?r pati~n~selection for angioplasty and I?appropnately limited angioplasty which was restncted to the femoral region and not extended to the tibial arteries. In the presence of severe infrapopliteal disease, angioplasty limited to thẽ uper?~ial femoral artery and popliteal artery is insufficient therapy.
Several factors have been shown to influence patency rates in femoropopliteal disease treated by angioplasty.s? Stenoses have better outcome than occlusions, shorter occlusions better than longer occlusions, and patients with two or three patent calf vessels fare better than with one or no patent vessels. Diabetes negatively affects longterm patency of femoral angioplasty and the most likely cause of this is the presence of untreated tibial disease. In the presence of significant distal disease, tibial angioplasty should be carried out in addition to femoral angioplasty.
Angioplasty is indicated in the management of the diabetic foot when angiography reveals segmental stenoses that do not exceed 3-5 em in length or occlusions of similar length that can be traversed wi.th a guide wire in order to carry out balloon angioplasty, Should the patient present with a long segmental occlusion of the superficial femoral artery or proxi~al popliteal artery, or should there be a long diffuse haemodynamically significant stenosis in those segments, then it is advisable to proceed with femoropopliteal reconstruction if the patient is fit.
There are three indications in which femoropopliteal angioplasty might be preferable to established operative procedures. Angioplasty is a low-risk effective procedure that can be used in patients whose symptoms might not be severe enough to warrant the risk of surgical intervention, e.g. a persistent unhealed ulcer but not threatening the leg. Angioplasty might be employed in conjunction with a limited vascular procedure in an effort to provide better inflow or outflow; thus, in combined femoral and tibial disease, a femoral angioplasty might be carried out to allow a jump graft between popliteal and distal vessels. Thirdly, angioplasty, because of its reported simplicity and inherent safety, can be employed in elderly and high-risk patients in whom the anticipated risk of surgery is prohibitive.
Tibial disease
In view of the predilection of diabetic macrovascular disease for tibial vessels, belowknee revascularization has become an important topic in the management of the diabetic foot. Tibial angioplasty works best with single or tnultiple short « 1 ern) stenoses or occlusions.
Much of diabetic calf disease consists of long segment occlusions in severely calcified vessels, in which angioplasty is difficult. The longer the length of disease tackled, the greater the likelihood of rethrombosis. However, technically, tibial angioplasty has become easier to perform over the last decade. The aim is to restore straight-line blood flow to the foot in at least one and preferably two vessels. Not surprisingly, poorer results can be expected where the angioplastied artery remains discontinuous with the vessels of the foot. However, some improvement can be expected in one-third of patients.
Initially, tibial angioplasty was carried out using tapered Van Andel catheters to effect dilatation, and success rates were low. Zeitler et al. Several reports have appeared since 1988 employing these new techniques but have included both patients with critical ischaemia and claudication. Each report has included both diabetic and nondiabetic patients and it is difficult to be sure exactly of the outcome in diabetic patients except when a specific comment was made about this particular group. Only one report has included diabetic patients only. Furthermore, tibial angioplasty in these patients was often necessarily combined with more proximal femoral angioplasty. Thus, clinical and haemodynamic improvements were obviously related to both femoral and tibial angioplasty.
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In a large series, Schwarten reported 96 patients with 146 below-knee angioplasties.w There were 31 total occlusions and 95 multiple stenoses; 60 patients were diabetic. The ankle/brachial pressure index increased from a mean of 0.25 before the procedure to 0.62 afterwards. At two years (35 patients), the mean ankle/brachial index was 0.55. Schwarten concluded that suitable tibial lesions are five or fewer stenoses and occlusions 5 em or less in length. Four patients had major amputations and these occurred in patients who had long segment anterior and posterior tibial occlusions with a short segment focal occlusion of the peroneal artery that could not be recanalized. These patients were all insulin-dependent diabetic patients.
Brown et al. reported angioplasty in 11 patients facing reconstructive surgery.w Ten of the 11 patients had diabetes. The procedure was a technical success in nine of 12 cases. Six of the nine cases remained clinically successful after a follow-up period of one and 22 months. Six patients underwent concomitant angioplasty of a more proximal lesion.
Bakal et al. reported the results of angioplasty in a series of 53 patients in whom there were 57 procedures; 76 infrapopliteal arteries were dilated including 26 anterior tibial arteries, ten posterior . t~bial arteries, 18 peroneal arteries, and 22. tibioperoneal trunks.> Thirty-three of the patients had concomitant angioplasties of the femoropopliteal arteries. In the first 14 procedures, tapered catheters were used and technical success occurred only in four (29%). In the succeeding 43 procedures (75%), balloon catheters and low profile balloons were used and the technical success was achieved in 27 procedures (86%). Prompt clinical improvement was seen in 3.2 of 40 technically successful procedures. Eighty-f~ve per cent o! the patients were diabetic. Straight line flow, defined as less than 25% stenosis in a tibial vessel to the foot was three times more likely to result in initial clinical success than in whom straight-line flow was not achieved.
Buckenham et al. reported 14 infrapopliteal angioplasties in 13 patients, of whom five were diabetic, with critical limb ischaernia.v' Clinical indications were rest pain, ulceration and gangrene, and of the 13 patients 11 (85%) showed early clinical improvement. Major amputation was required in two patients, one of which was for diabetic gangrene.
In a further series reported by Dorros et al. conventional balloon angioplasty was attempted in 111 patients and 168 below-knee tibioperoneal vessels were dilated. 36 However, the predominant symptoms were claudication in 47%, nonhealing ulcers and gangrene in 27% and rest pain in 26%. An above-knee vessel was dilated before tibioperoneal angioplasty in 56%. A successful angioplasty was achieved in 90% of tibioperoneal vessels. At discharge, 95% of patients were clinically improved but 36% of patients had lesion recurrence with or without new disease and 64% showed evidence of disease progression.
In a series by Wagner et al., during a one-year period, a total of 226 infrapopliteal angioplasties were carried out in 148 patients, although 19% were accompanied by thrombus aspiration and 11.9% by local thrombolysis.e? Primary angiographic success was achieved in 95% and primary clinical success in 89.9%. The follow-up period revealed a limb salvage rate of 88.8% by lifetable analysis and 67% of the patients had clinically improved limbs. Sixty-eight of the patients were diabetic and they had a worse prognosis in that 82% of the nondiabetic patients had long-term clinical improvement compared with 58.1 % diabetic patients.
Saab et al. reported angioplasty in 17 tibial arteries with an average cross-sectional area of stenosis of 92% in 13 patients for limb salvage. 38 There were nine diabetics. Six patients with nonhealing wounds had partial (two patients) or complete (four patients) healing with one requiring toe amputations but, of six patients with gangrene, two had a below-knee amputation, one continued to demonstrate poor healing of a transmetatarsal amputation site and one showed no further progression. Thus,·in only two out of six limbs with gangrene was early clinical success achieved. In conclusion, Saab et al. noted that short segmental stenoses, residual stenoses less than 40% following angioplasty and absence of diabetes or gangrene appeared to be predictors of favourable outcome.
Fourteen consecutive diabetic patients underwent tibial angioplasty for treatment of limbthreatening ischaemia.wAngioplasty was selected over conventional bypass procedures because of a lack of autogenous conduit or because of an unacceptably high surgical risk. Long-term limb salvage was achieved in 77% over a mean followup of 17 months.
In conclusion, these reports have demonstrated that tibial angioplasty is a useful technique in the diabetic patient with critical limb ischaemia. In particular, short segment stenoses and occlusions less than 5 em are amenable to angioplasty (Figures 1 and 2) . Angioplasty should also be used to treat more extensive lesions in patients who are unfit for conventional bypass. However, the overall results are not as favourable as in the nondiabetics.
Complications of angioplastỹ
e complications of angioplasty are normally rmnor and rarely require surgical intervention. They were reviewed by Gardiner et al. with par~icular .reference to iliac and femoropopliteal angioplasties.w The commonest complications occur at the puncture site and the most usual of these is haematoma formation (4%). Puncture site thrombosis (1%) and false aneurysm formation (1%) are the other puncture site complications. Complications at the angioplasty site are less common and include acute thrombosis (1%) and subintimal dissection (2%) but there are rarely any clinical sequelae from dissection. Acute thrombosis can be treated in most cases by thrombolysis.
Complications of tibial angioplasties have been documented in recent reports. In the Saab series, there were two groin haematomas out of 17 angioplasties.v' Schwarten reported thrombosis at the angioplasty site in four out of 125 cases. 32 Bakal et al. 
Precautions
In order to avoid the complications described above, certain precautions should be taken both before and during the procedure.
Preangioplasty assessment should include a platelet count, prothrombin time, urea and electrolytes, electrocardiograph and chest radiograph. The patient should be well hydrated, preferably on intravenous fluids and insulin pump. Low osmolar non ionic contrast agents should always be used though these are not free from adverse effects. A creatinine in the high normal range or only just above often represents a significant reduction in creatinine clearance and these patients are susceptible to a further reduction in renal function with increasing dose of contrast, which should therefore be kept to a minimum. Careful monitoring of renal function postprocedure is mandatory. There may be an advantage for patients with established mild to moderate renal failure (creatinine> 120 mmol/l) in commencing either a low renal dose of dopamine (2.5 j.Lg/kg per hourr'! or the osmotic diuretic mannitol-e at the start of the procedure.
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The exact role of these agents is not clear and controlled trials are needed to evaluate them further. Intravenous access should be established prior to any procedure and angioplasties must have continuous electrocardiographic and blood pressure monitoring. Postangiography care, especially if angioplasty has been performed, is important and should take place on units with specially trained staff.
All patients undergoing angioplasty are commenced on aspirin 150 mg/day, the day before the procedure and to be continued indefinitely. Routine use of vasodilators in distal angioplasties has reduced the incidence of spasm-induced thrombosis postprocedure; 20 mg of nifedipine prior to the procedure, or 1 mg boluses of intraarterial isosorbide dinitrate during the procedure usually suffices. Heparin should be used routinely intra-arterially and 5000 units covers most procedures. 
Follow-up
Angioplasty is often tried as an initial procedure in reopening stenosed or occluded arteries. It is imperative to follow up the patient after angioplasty. 43, 44 The patient should be examined at regular intervals and haemodynamic parameters measured. Anklelbrachial pressure index can be used for follow-up . A recent study has advocated the use of duplex scanning to examine the angioplasty site so as to rapidly diagnose restenosis.s"
Conclusions
Angioplasty has established a place in the treatment of critical ischaemia of the lower limb , including the diabetic foot. Given the same lesion , a diabetic will do equally as well as a nondiabetic postangioplasty, assuming equality of other factors such as inflow and run-off .
Ie)
Although angioplasty is often advocated as the initial management of vascular disease , it does not preclude surgery. However, there should be modest expectations with very careful follow-up , preferably by serial measurements of ankle/brachial systolic pressure index and duplex scanning.
Thus, in selected patients, angioplasty of infrapopliteal vessels is a procedure of choice with distal bypass surgery reserved for those patients in whom technical success can not be achieved or in whom technical success is not accompanied by clinical improvement. Angioplasty is particularly useful for treatment of the persistent unhealed ulcer in an ischaemic foot when a modest increase in pressure index will facilitate healing. However, in cases of severe tissue loss and gangrene, it is usually necessary to restore pulsatile blood flow by distal bypass if the patient is fit enough for surgery. In the elderly frail diabetic, when surgery is totally contraindicated, angioplasty may be carried out even in cases of severe tissue loss or multiple stenoses and long occlusions. This may save the foot although not necessarily achieve total healing.
Ib)
One principle has been established: it is important to achieve straight-line flow to the foot. In the presence of severe infrapopliteal disease, angioplasty of the superficial femoral and popliteal artery is usually insufficient and it is preferable to achieve straight-line blood flow to the foot via one or two tibial arteries.
If a patient has a lesion that can be treated with a transcatheter technique, primarily balloon angioplasty, then that less invasive procedure is clearly in the patient's best interest and should be the initial form of therapy. The second report of the European Consensus on Critical Ischaemia recommends that, if angiography shows a technically suitable lesion and an experienced radiologist is available, a percutaneous catheter procedure should be tried as the first option even though surgery may eventually be needed. This recommendation is particularly pertinent to the diabetic foot.
